𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and feasibility of cyclophosphamide combined with intermediate- dose or high-dose cytarabine for relapsed and refractory acute myeloid leukemia (AML)

✍ Scribed by Schnetzke, Ulf; Fix, Peter; Spies-Weisshart, Baerbel; Schrenk, Karin; Glaser, Anita; Fricke, Hans-Joerg; La Rosée, Paul; Hochhaus, Andreas; Scholl, Sebastian

Book ID
125347629
Publisher
Springer-Verlag
Year
2014
Tongue
English
Weight
268 KB
Volume
140
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose liposomal daunorubicin and hig
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
✍ Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Background: Liposomal encapsulation of daunorubicin (daunoxome, dnx; nexstar pharmaceutical, boulder, co) changes the pharmacology profile to increase delivery to tumor sites and decrease toxicity. the authors investigated the effect of daunorubicin in combination with ara-c in patients with ref